Akihiro Seki

Kanazawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

A decade of clinical course and prognostic determinants in type 1 autoimmune pancreatitis: insights from a 10-year longitudinal multicenter retrospective study.

A decade of clinical course and prognostic determinants in type 1 autoimmune pancreatitis: insights from a 10-year longitudinal multicenter retrospective study.

Journal: Journal of gastroenterology

Published: March 19, 2026

Pilot validation of a whole-blood mRNA expression-based diagnostic system for early-stage pancreatic ductal adenocarcinoma: a single-center case-control diagnostic accuracy study.

Pilot validation of a whole-blood mRNA expression-based diagnostic system for early-stage pancreatic ductal adenocarcinoma: a single-center case-control diagnostic accuracy study.

Journal: Scientific reports

Published: March 16, 2026

Potential Role of Liver Transplantation for Child-Pugh Class A Hepatocellular Carcinoma: Prognosis and Medical Expenditure in Japan-A Retrospective Single-Center Study.

Potential Role of Liver Transplantation for Child-Pugh Class A Hepatocellular Carcinoma: Prognosis and Medical Expenditure in Japan-A Retrospective Single-Center Study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 16, 2025

Disseminated Mucormycosis with Characteristic Gastric Ulcers and Extensive Intravascular Invasion after ABO-Incompatible Living-Donor Liver Transplantation: A Case Report.

Disseminated Mucormycosis with Characteristic Gastric Ulcers and Extensive Intravascular Invasion after ABO-Incompatible Living-Donor Liver Transplantation: A Case Report.

Journal: Surgical case reports

Published: October 15, 2025

Clinical Impact of Recurrence Beyond the Milan Criteria After Curative Resection of Hepatocellular Carcinoma.

Clinical Impact of Recurrence Beyond the Milan Criteria After Curative Resection of Hepatocellular Carcinoma.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: September 28, 2025

Spotlight on AMIGO2 as a novel prognostic indicator in pancreatic cancer.

Spotlight on AMIGO2 as a novel prognostic indicator in pancreatic cancer.

Journal: Journal of gastrointestinal oncology

Published: July 29, 2025

Utility of oral rehydration jelly in probe method endoscopic ultrasound: a prospective cohort study.

Utility of oral rehydration jelly in probe method endoscopic ultrasound: a prospective cohort study.

Journal: Therapeutic advances in gastroenterology

Published: July 14, 2025

Therapeutic effects of adipose tissue-derived mesenchymal stem cells on ER stress in a murine model of metabolic dysfunction-associated steatohepatitis: an in vivo and in vitro study.

Therapeutic effects of adipose tissue-derived mesenchymal stem cells on ER stress in a murine model of metabolic dysfunction-associated steatohepatitis: an in vivo and in vitro study.

Journal: Stem cell research & therapy

Published: April 15, 2025

Optimizing Photodynamic Therapy for Cervical Esophageal Cancer: A Novel Technique for Precise Lesion Targeting by Transnasal Thin Endoscopy and Upward-Facing Attachment.

Optimizing Photodynamic Therapy for Cervical Esophageal Cancer: A Novel Technique for Precise Lesion Targeting by Transnasal Thin Endoscopy and Upward-Facing Attachment.

Journal: Cureus

Published: March 26, 2025

Metachronous Pancreatic Cancer with Pancreaticobiliary Maljunction Diagnosed Five Years after Cholecystectomy for Gallbladder Cancer, in Which Follow-up Imaging Was Possible Until the Onset of Cancer: A Case Report and Review of the Literature.

Metachronous Pancreatic Cancer with Pancreaticobiliary Maljunction Diagnosed Five Years after Cholecystectomy for Gallbladder Cancer, in Which Follow-up Imaging Was Possible Until the Onset of Cancer: A Case Report and Review of the Literature.

Journal: Internal medicine (Tokyo, Japan)

Published: January 15, 2025

Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib.

Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib.

Journal: Cancers

Published: December 27, 2024

Antibody-mediated rejection without elevated anti-blood type antibody after ABO-incompatible living donor liver transplantation: a case report.

Antibody-mediated rejection without elevated anti-blood type antibody after ABO-incompatible living donor liver transplantation: a case report.

Journal: Clinical journal of gastroenterology

Published: December 11, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026